Biomarkers of human exposure to acrylamide and relation to polymorphisms in metabolizing genes

Toxicological Sciences

Volumn 108, Issue 1, 2009, Pages 90-99

  Duale, Nur ^a   Bjellaas, Thomas ^a   Alexander, Jan ^a   Becher, Georg ^a   Haugen, Margaretha ^a   Paulsen, Jan Erik ^a   Frandsen, Henrik ^b   Olesen, Pelle Thonning ^b   Brunborg, Gunnar ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

Acrylamide; Biotransformation; Cytochrome P450 2E1; Glutathione S transferase; Glycidamide; Polymorphisms; SNPs

Indexed keywords

ACRYLAMIDE; ARGININE; BIOLOGICAL MARKER; CYTOCHROME P450 2E1; EPOXIDE HYDROLASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; GLYCIDAMIDE; HEMOGLOBIN; HISTIDINE; TYROSINE; VALINE;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; DETOXIFICATION; DIETARY INTAKE; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENETIC CODE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTOXICITY; GENOTYPE; HUMAN; LIVER MICROSOME; MALE; RISK ASSESSMENT; WILD TYPE;

ACRYLAMIDE; ADULT; AGED; BIOMARKERS, PHARMACOLOGICAL; CHI-SQUARE DISTRIBUTION; CYTOCHROME P-450 CYP2E1; EPOXIDE HYDROLASES; EPOXY COMPOUNDS; FEMALE; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HEMOGLOBINS; HUMANS; MALE; METABOLIC DETOXICATION, DRUG; MIDDLE AGED; POLYMORPHISM, GENETIC; STATISTICS, NONPARAMETRIC;

EID: 61349192330     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfn269     Document Type: Article

References (49)

1. Abdel-Rahman, S. Z., el Zein, R. A., Anwar, W. A., and Au, W. W. (1996). A multiplex PCR procedure for polymorphic analysis of GSTM1 and GSTT1 genes in population studies. Cancer Lett. 107, 229-233.
2. Ali-Osman, F., Akande, O., Antoun, G., Mao, J. X., and Buolamwini, J. (1997). Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J. Biol. Chem. 272, 10004-10012.
3. Autrup, H. (2000). Genetic polymorphisms in human xenobiotica metabolizing enzymes as susceptibility factors in toxic response. Mutat. Res. 464, 65-76.
4. Benhamou, S., Reinikainen, M., Bouchardy, C., Dayer, P., and Hirvonen, A. (1998). Association between lung cancer and microsomal epoxide hydrolase genotypes. Cancer Res. 58, 5291-5293.
5. Bjellaas, T., Olesen, P. T., Frandsen, H., Haugen, M., Stolen, L. H., Paulsen, J. E., Alexander, J., Lundanes, E., and Becher, G. (2007). Comparison of estimated dietary intake of acrylamide with hemoglobin adducts of acrylamide and glycidamide. Toxicol. Sci. 98, 110-117.
6. Board, P. G. (1981). Biochemical genetics of glutathione-S-transferase in man. Am. J. Hum. Genet. 33, 36-43.
7. Brantsaeter, A. L., Haugen, M., Mul, A., Bjellaas, T., Becher, G., Klaveren, J. V., Alexander, J., and Meltzer, H. M. (2008). Exploration of different methods to assess dietary acrylamide exposure in pregnant women participating in the Norwegian Mother and Child Cohort Study (MoBa). Food Chem. Toxicol. 46, 2808-2814.
8. Butkiewicz, D., Grzybowska, E., Hemminki, K., Ovrebo, S., Haugen, A., Motykiewicz, G., and Chorazy, M. (1998). Modulation of DNA adduct levels in human mononuclear white blood cells and granulocytes by CYP1A1 CYP2D6 and GSTM1 genetic polymorphisms. Mutat. Res. 415, 97-108.
9. Cotton, S. C., Sharp, L., Little, J., and Brockton, N. (2000). Glutathione S-transferase polymorphisms and colorectal cancer: A HuGE review. Am. J. Epidemiol. 151, 7-32.
10. Dearfield, K. L., Douglas, G. R., Ehling, U. H., Moore, M. M., Sega, G. A., and Brusick, D. J. (1995). Acrylamide: A review of its genotoxicity and an assessment of heritable genetic risk. Mutat. Res. 330 71-99.
11. Doerge, D. R., da Costa, G. G., McDaniel, L. P., Churchwell, M. I., Twaddle, N. C., and Beland, F. A. (2005). DNA adducts derived from administration of acrylamide and glycidamide to mice and rats. Mutat. Res. 580, 131-141.
12. Fairbrother, K. S., Grove, J., de, W. I., Steimel, D. T., Day, C. P., Crespi, C. L., and Daly, A. K. (1998). Detection and characterization of novel polymorphisms in the CYP2E1 gene. Pharmacogenetics 8, 543-552.
13. Fost, U., Tornqvist, M., Leutbecher, M., Granath, F., Hallier, E., and Ehrenberg, L. (1995). Effects of variation in detoxification rate on dose monitoring through adducts. Hum. Exp. Toxicol. 14, 201-203.
14. Garte, S., Gaspari, L., Alexandrie, A. K., Ambrosone, C., Autrup, H., Autrup, J. L., Baranova, H., Bathum, L., Benhamou, S., Boffetta, P., et al. (2001). Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol. Biomarkers Prev. 10, 1239-1248.
15. Ghanayem, B. I., McDaniel, L. P., Churchwell, M. I., Twaddle, N. C., Snyder, R., Fennell, T. R., and Doerge, D. R. (2005). Role of CYP2E1 in the epoxidation of acrylamide to glycidamide and formation of DNA and hemoglobin adducts. Toxicol. Sci. 88, 311-318.
16. Hagmar, L., Wirfalt, E., Paulsson, B., and Tornqvist, M. (2005). Differences in hemoglobin adduct levels of acrylamide in the general population with respect to dietary intake, smoking habits and gender. Mutat. Res. 580, 157-165.
17. Hanioka, N., Tanaka-Kagawa, T., Miyata, Y., Matsushima, E., Makino, Y., Ohno, A., Yoda, R., Jinno, H., and Ando, M. (2003). Functional characterization of three human cytochrome p450 2E1 variants with amino acid substitutions. Xenobiotica 33, 575-586.
18. Hassett, C., Aicher, L., Sidhu, J. S., and Omiecinski, C. J. (1994). Human microsomal epoxide hydrolase: Genetic polymorphism and functional expression in vitro of amino acid variants. Hum. Mol. Genet. 3 421-428.
19. Hayes, J. D., and Strange, R. C. (1995). Potential contribution of the glutathione S-transferase supergene family to resistance to oxidative stress. Free Radic. Res. 22, 193-207.
20. Ho, C. T. (2006). Maillard reaction and health aspects. Mol. Nutr. Food Res. 50, 1099-1100.
21. Hosagrahara, V. P., Rettie, A. E., Hassett, C., and Omiecinski, C. J. (2004). Functional analysis of human microsomal epoxide hydrolase genetic variants. Chem. Biol. Interact. 150, 149-159.
22. IARC. (1994). IARC: Acrylamide. IARC Monogr. Eval. Carcinog. Risks Hum. 60, 389-433, 389-433.
23. Ichiba, M., Hagmar, L., Rannug, A., Hogstedt, B., Alexandrie, A. K., Carstensen, U., and Hemminki, K. (1994). Aromatic DNA adducts, micronuclei and genetic polymorphism for CYP1A1 and GST1 in chimney sweeps. Carcinogenesis 15, 1347-1352.
24. Kirman, C. R., Gargas, M. L., Deskin, R., Tonner-Navarro, L., and Andersen, M. E. (2003). A physiologically based pharmacokinetic model for acrylamide and its metabolite, glycidamide, in the rat. J. Toxicol. Environ. Health A 66, 253-274.
25. Mannervik, B., Awasthi, Y. C., Board, P. G., Hayes, J. D., Di Ilio, C., Ketterer, B., Listowsky, I., Morgenstern, R., Muramatsu, M., Pearson, W. R., et al. (1992). Nomenclature for human glutathione transferases. Biochem. J. 282, 305-306.
26. Meyer, D. J., Coles, B., Pemble, S. E., Gilmore, K. S., Fraser, G. M., and Ketterer, B. (1991). Theta, a new class of glutathione transferases purified from rat and man. Biochem. J. 274, 409-414.
27. Mottram, D. S., Wedzicha, B. L., and Dodson, A. T. (2002). Acrylamide is formed in the Maillard reaction. Nature 419, 448-449.
28. Nelson, H. H., Wiencke, J. K., Christiani, D. C., Cheng, T. J., Zuo, Z. F., Schwartz, B. S., Lee, B. K., Spitz, M. R., Wang, M., Xu, X., et al. (1995). Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta. Carcinogenesis 16, 1243-1245.
29. Olesen, P. T., Olsen, A., Frandsen, H., Frederiksen, K., Overvad, K., and Tjonneland, A. (2008). Acrylamide exposure and incidence of breast cancer among postmenopausal women in the Danish Diet, Cancer and Health Study. Int. J. Cancer 122, 2094-2100.
30. Ollikainen, T., Hirvonen, A., and Norppa, H. (1998). Influence of GSTT1 genotype on sister chromatid exchange induction by styrene-7,8-oxide in cultured human lymphocytes. Environ. Mol. Mutagen. 31, 311-315.
31. Omiecinski, C. J., Hassett, C., and Hosagrahara, V. (2000). Epoxide hydrolase - Polymorphism and role in toxicology. Toxicol. Lett. 112-113, 365-370.
32. Paulsson, B., Rannug, A., Henderson, A. P., Golding, B. T., Tornqvist, M., and Warholm, M. (2005). In vitro studies of the influence of glutathione transferases and epoxide hydrolase on the detoxification of acrylamide and glycidamide in blood. Mutat. Res. 580, 53-59.
33. Pemble, S., Schroeder, K. R., Spencer, S. R., Meyer, D. J., Hallier, E., Bolt, H. M., Ketterer, B., and Taylor, J. B. (1994). Human glutathione S-transferase theta (GSTT1): CDNA cloning and the characterization of a genetic polymorphism. Biochem. J. 300, 271-276.
34. Peter, H., Deutschmann, S., Muelle, A., Gansewendt, B., Bolt, M., and Hallier, E. (1989). Different affinity of erythrocyte glutathione-S-transferase to methyl chloride in humans. Arch. Toxicol. Suppl. 13, 128-132.
35. Rebbeck, T. R. (1997). Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol. Biomarkers Prev. 6, 733-743.
36. Ryberg, D., Kure, E., Lystad, S., Skaug, V., Stangeland, L., Mercy, I., Borresen, A. L., and Haugen, A. (1994). p53 mutations in lung tumors: Relationship to putative susceptibility markers for cancer. Cancer Res. 54, 1551-1555.
37. Ryberg, D., Skaug, V., Hewer, A., Phillips, D. H., Harries, L. W., Wolf, C. R., Ogreid, D., Ulvik, A., Vu, P., and Haugen, A. (1997). Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis 18, 1285-1289.
38. Salama, S. A., Abdel-Rahman, S. Z., Sierra-Torres, C. H., Hamada, F. A., and Au, W. W. (1999). Role of polymorphic GSTM1 and GSTT1 genotypes on NNK-induced genotoxicity. Pharmacogenetics 9, 735-743.
39. Schoket, B., Papp, G., Levay, K., Mrackova, G., Kadlubar, F. F., and Vincze, I. (2001). Impact of metabolic genotypes on levels of biomarkers of genotoxic exposure. Mutat. Res. 482, 57-69.
40. Segerback, D., Calleman, C. J., Schroeder, J. L., Costa, L. G., and Faustman, E. M. (1995). Formation of N-7-(2-carbamoyl-2-hydroxyethyl)-guanine in DNA of the mouse and the rat following intraperitoneal administration of [14C]acrylamide. Carcinogenesis 16, 1161-1165.
41. Stadler, R. H., Blank, I., Varga, N., Robert, F., Hau, J., Guy, P. A., Robert, M. C., and Riediker, S. (2002). Acrylamide from Maillard reaction products. Nature 419, 449-450.
42. Sumner, S. C., Fennell, T. R., Moore, T. A., Chanas, B., Gonzalez, F., and Ghanayem, B. I. (1999). Role of cytochrome P450 2E1 in the metabolism of acrylamide and acrylonitrile in mice. Chem. Res. Toxicol. 12, 1110-1116.
43. Sumner, S. C., MacNeela, J. P., and Fennell, T. R. (1992). Characterization and quantitation of urinary metabolites of [1,2,3-13C]acrylamide in rats and mice using 13C nuclear magnetic resonance spectroscopy. Chem. Res. Toxicol. 5, 81-89.
44. Sumner, S. C., Selvaraj, L., Nauhaus, S. K., and Fennell, T. R. (1997). Urinary metabolites from F344 rats and B6C3F1 mice coadministered acrylamide and acrylonitrile for 1 or 5 days. Chem. Res. Toxicol. 10, 1152-1160.
45. The International HapMap Project. (2003). The International HapMap Project. Nature 426, 789-796.
46. Thorisson, G. A., Smith, A. V., Krishnan, L., and Stein, L. D. (2005). The International HapMap Project Web site. Genome Res. 15, 1592-1593.
47. Tornqvist, M., Fred, C., Haglund, J., Helleberg, H., Paulsson, B., and Rydberg, P. (2002). Protein adducts: Quantitative and qualitative aspects of their formation, analysis and applications. J. Chromatogr. B 778, 279-308.
48. Vesper, H. W., Slimani, N., Hallmans, G., Tjonneland, A., Agudo, A., Benetou, V., Bingham, S., Boeing, H., Boutron-Ruault, M. C., Buenode-Mesquita, H. B., et al. (2008). Cross-sectional study on acrylamide hemoglobin adducts in subpopulations from the European Prospective Investigation into Cancer and Nutrition (EPIC) Study. J. Agric. Food Chem. 56, 6046-6053.
49. Wenzlaff, A. S., Cote, M. L., Bock, C. H., Land, S. J., and Schwartz, A. G. (2005). GSTM1, GSTT1 and GSTP1 polymorphisms, environmental tobacco smoke exposure and risk of lung cancer among never smokers: A population-based study. Carcinogenesis 26, 395-401.